Nanoscience enables ultrasensitive detection of alzheimer s biomarker
Download
1 / 6

Nanoscience enables ultrasensitive detection of Alzheimer's biomarker - PowerPoint PPT Presentation


  • 100 Views
  • Uploaded on

Christine D. Keating . PNAS 2005, 102, No. 7, 2263 –2264 Jwa-Min Nam, Shad Thaxton, Chad A. Mirkin. Science 2003, 301, 1884-1886. Nanoscience enables ultrasensitive detection of Alzheimer's biomarker. Student: Xu Zhang. Alzheimer's disease.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about ' Nanoscience enables ultrasensitive detection of Alzheimer's biomarker' - sana


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
Nanoscience enables ultrasensitive detection of alzheimer s biomarker

Christine D. Keating . PNAS 2005, 102, No. 7, 2263 –2264

Jwa-Min Nam, Shad Thaxton, Chad A. Mirkin. Science 2003, 301, 1884-1886

Nanoscience enables ultrasensitive detection of Alzheimer's biomarker

Student: Xu Zhang


Alzheimer s disease
Alzheimer's disease

  • Alzheimer's disease (AD), which afflicts an estimated 16 million people worldwide, is a neurodegenerative dementia characterized by memory loss and cognitive impairment.

  • Symptoms begin with mild cognitive impairment.

  • It’s tough to distinguish from other more benign forms of age-related dementia.


Alzheimer s disease1
Alzheimer's disease

  • Smaller, soluble oligomers of peptides, referred to as amyloid--derived diffusible ligands (ADDLs), have recently been hypothesized as the causative agent in AD-related memory loss.

  • Support for the role of ADDLs comes from their neurotoxicity, and mouse studies that indicate a reversal of memory loss upon injection of amyloid- antibodies

  • This paper presented an ultrasensitive, nanoparticle-based protein detection strategy termed bio-barcode amplification (BCA) to detect ADDL concentration in the cerebrospinal fluid (CSF).


Bio barcode amplification bca strategy
Bio-barcode Amplification (BCA) Strategy

  • CSF is first exposed to monoclonal anti-ADDL antibodies bound to magnetic microparticles.

  • After ADDL binding, the microparticles are separated with a magnetic field and washed before addition of secondary antibodies bound to DNA:Au nanoparticle conjugates.

  • Unreacted Au nanoparticle conjugates are removed after magnetic separation, then elevated temperature release the barcode DNA for analysis.

  • Each Au nanosphere carries hundreds of identical barcode DNA strands, providing substantial amplification.


Scanometric dna detection
Scanometric DNA detection

  • The probe strands are arrayed on a solid support and the detection strand is bound to an Au nanosphere.

  • The selectively assembled Au nanospheres then act as nucleation sites for Ag deposition upon the chemical reduction of Ag+ from solution.

  • The resulting Ag deposits can be quantified by a simple desktop scanner such as is used to scan documents for computer manipulation (hence scanometric)


Advantages
Advantages

  • Ultrasentivity with built-in signal amplification mechanism. 30 attomolar (30 x 10-18 M) for protein targets, useful for early diagnosis.

  • Can also be applicable for DNA or RNA diagnosis, or simultaneously multiple monitoring.

  • Rapid diagnosis due to performing the BCA assay in homogeneous suspension.

  • It marks one of the first real applications of nanotechnology, while the vast majority of the countless publications on nanoparticle-based diagnostics are in the proof-of-principle stage.


ad